annb0t
Top 20
Incannex Healthcare
MELBOURNE, Australia, May 03, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (âIncannexâ or âthe Companyâ) is pleased to announce a company presentation containing data and analysis of the results from the Phase 1 clinical trial undertaken to assess safety and pharmacokinetics of IHL-675A as an anti-inflammatory drug candidate.
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
...
>>> Read more: Incannex Company Presentation â Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
MELBOURNE, Australia, May 03, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (âIncannexâ or âthe Companyâ) is pleased to announce a company presentation containing data and analysis of the results from the Phase 1 clinical trial undertaken to assess safety and pharmacokinetics of IHL-675A as an anti-inflammatory drug candidate.
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
...
>>> Read more: Incannex Company Presentation â Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
